In 567 PH-COPD patients from the PVRI GoDeep Meta-Registry, ACE inhibitor use was associated with improved survival only in severe PH (PVR > 5 WU), supporting prospective trials targeting this high-risk subgroup.
- Yogeswaran, A.
- Funderich, M.
- Wendlandt, K.
- Annis, J. S.
- Brittain, E.
- Eichstaedt, C. A.
- Grunig, E.
- Cajigas, H. R.
- Frantz, R.
- Sweatt, A. J.
- Zamanian, R. T.
- Grimminger, F.
- Wilhelm, J.
- Ghofrani, H. A.
- Tello, K.
- Seeger, W.
- Pvri GoDeep Consortium
